| REVIEW ARTICLE |
|
| Year : 2022 | Volume
: 21
| Issue : 2 | Page : 100-103 |
|
|
Cardiovascular health in turner syndrome: Manifestations, endocrine, and metabolic risk factors with a look at clinical practice
Wasnaa Hadi Abdullah1, Abdulameer Jasim Jawad al-Gburi2, Saba Ryadh Younis Al-Obaidi3
1 Department of Pediatrics, Al-Mustansiriyah University, College of Medicine, Baghdad, Iraq
2 Department of Medicine, College of Medicine, Al-Mustansiriyah University, Baghdad, Iraq
3 Department of Obstetrics and Gynecology, College of Medicine, Al-Nahrain University, Baghdad, Iraq
Correspondence Address:
Dr. Wasnaa Hadi Abdullah
Department of Pediatrics, Al-Mustansiriyah University, College of Medicine, Baghdad
Iraq
 Source of Support: None, Conflict of Interest: None
DOI: 10.4103/mj.mj_13_22
|
|
|
Turner syndrome (TS) is the most frequent female chromosomal abnormality, with a higher overall mortality rate than the general population; cardiovascular events are a significant risk factor. Cardiovascular manifestations in TS include congenital heart diseases, in addition to acquired heart diseases such as acute aortic dissection, stroke, myocardial infarction, and hypertension. Growth hormone-insulin growth factor 1 axis abnormality, estrogen hormone deficiency, liability for diabetes mellitus, and dyslipidemia all are endocrine risk factors affecting cardiovascular health in TS. Heart anatomical defects should be closely monitored for progression and associated complications throughout the patient's lifetime by a skilled cardiologist. |
|
|
|
| [FULL TEXT] [PDF]* |
|
 |
|
